ACUTE HEART FAILURE AND DECOMPENSATED HEART FAILURE: THE IMPORTANCE OF MULTIMORBIDITY (LITERATURE REVIEW)

Highlights

Understanding the interaction between various diseases in patients with acute heart failure and acute decompensated heart failure is key to developing effective prevention and management strategies aimed at improving the quality of medical care and reducing morbidity and mortality among this group of patients.

Abstract

Acute decompensated heart failure (ADHF) is a serious clinical condition that is often accompanied by multimorbidity, i.e. the presence of several chronic diseases simultaneously. These comorbidities significantly complicate the diagnosis, treatment and prognosis of outcomes in patients with ADHF. The review considers the most common comorbid conditions, such as arterial hypertension, diabetes mellitus, chronic kidney disease, obesity, depression and cognitive impairment. Each of these factors individually, as well as together (synergistically), affects the course of ADHF, increasing the risk of complications and worsening the patient's quality of life. Emphasizes the importance of an integrated approach to the management of patients with ADHF and multimorbidity. Early detection and pathogenetic therapy of comorbidities can reduce the frequency of hospitalizations, improve the functional capabilities of patients and increase life expectancy. Thus, understanding the interactions between various diseases in patients with ADHF is key to developing effective prevention and treatment strategies aimed at improving the quality of medical care and reducing morbidity and mortality in this group of patients.

1. Shlyakhto E.V., Belenkov Yu.N., Boytsov S.A., Villevalde S.V., Galyavich A.S., Glezer N.G., Zvartau N.E., Kobalava Zh.D., et al. Interim analysis of a prospective observational multicenter registry study of patients with chronic heart failure in the Russian Federation "PRIORITET-CHF": initial characteristics and treatment of the first included patients. Russian Journal of Cardiology. 2023; 28(10): 5593. doi:10.15829/1560-4071-2023-5593. (In Russian)

2. Fomin I.V., Belenkov Yu.N., Mareev V.Yu., Ageev F.T., Artemyeva E.G., Badin Yu.V., Bakulina E.V., Weisberg A.R., et al. EPOCH-CHF As A Mirror of the Current Problems in Cardiovascular Diseases Treatment in Real Clinical Practice. Kardiologiia. 2024;64(11):48-61. doi:10.18087/cardio.2024.11.n2808. (In Russian.)

3. McDonagh T.A., Metra M., Adamo M., Gardner R.S. Baumbach A., Böhm M., Burri H., Butler J., et al. ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42(36): 3599-3726. doi: 10.1093/eurheartj/ehab368.

4. van de Veerdonk M.C., Savarese G., Handoko M.L., Beulens J.W.J. Asselbergs F., Uijl A. Multimorbidity in Heart Failure: Leveraging Cluster Analysis to Guide Tailored Treatment Strategies. Curr Heart Fail Rep. 2023;20(5):461-470. doi: 10.1007/s11897-023-00626-w.

5. Fonarow G.C., Stough W.G., Abraham W.T., Albert N.M., Gheorghiade M., Greenberg B.H., O'Connor C.M., Sun J.L.,et al. OPTIMIZE-HF Investigators and Hospitals. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol. 2007; 50(8): 768-77. doi: 10.1016/j.jacc.2007.04.064.

6. Hillege H.L., Girbes A.R., de Kam P.J., Boomsma F., de Zeeuw D., Charlesworth A., Hampton J.R., van Veldhuisen D.J. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000; 102(2): 203-10. doi: 10.1161/01.cir.102.2.203.

7. Joseph P., Dokainish H., McCready T., Budaj A., Roy A., Ertl G., Gomez-Mesa J.E., Leong D., Ezekowitz J., et al. G-CHF Investigators. A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry. Am Heart J. 2020; 227: 56-63. doi: 10.1016/j.ahj.2020.06.002.

8. Leong D.P., Joseph P., McMurray J.J.V., Rouleau J., Maggioni A.P., Lanas F., Sharma S.K., Núñez J., et al. Frailty and outcomes in heart failure patients from high-, middle-, and low-income countries. Eur Heart J. 2023; 44(42): 4435-4444. doi: 10.1093/eurheartj/ehad595.

9. Joseph P., Roy A., Lonn E., Störk S., Floras J., Mielniczuk L., Rouleau J.L., Zhu J. et al. Global Variations in Heart Failure Etiology, Management, and Outcomes. JAMA. 2023; 329(19): 1650-1661. doi: 10.1001/jama.2023.5942.

10. Khan M.S., Shahid I., Bennis A., Rakisheva A., Metra M., Butler J. Global epidemiology of heart failure. Nat Rev Cardiol. 2024;21(10):717-734. doi: 10.1038/s41569-024-01046-6.

11. Arrigo M., Jessup M., Mullens W., Reza N., Shah A.M., Sliwa K., Mebazaa A. Acute heart failure. Nat Rev Dis Primers. 2020;6(1):16. doi: 10.1038/s41572-020-0151-7.

12. Hammill S.C., Packer D.L. Amiodarone in congestive heart failure: unravelling the GESICA and CHF-STAT differences. Heart;75(1):6-7. doi: 10.1136/hrt.75.1.6.

13. Galyavich A.S., Tereshchenko S.N., Uskach T.M., Ageev F.T., Aronov D.M., Arutyunov G.P., Begrambekova Yu.L., Belenkov Yu.N., et al. 2024 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2024;29(11):6162. doi:10.15829/1560-4071-2024-6162. (In Russian)

14. Polyakov D.S., Fomin I.V., Belenkov Yu.N., Mareev V.Yu., Ageev F.T., Artemjeva E.G., Badin Yu.V., Bakulina E.V., et al. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia. 2021;61(4):4-14. doi:10.18087/cardio.2021.4.n1628. (In Russian)

15. Zvartau N.E., Solovyova A.E., Endubaeva G.V., Medvedev A.E., Solovyov A.E., Avdonina N.G., Yakovlev A.N., Apsheva E.A., et al. Analysis of the information about the incidence of heart failure, associated mortality and burden on the healthcare system, based on the encoding data in 15 subjects of the Russian Federation. Russian Journal of Cardiology. 2023;28(2S):5339. doi:10.15829/1560-4071-2023-5339. (In Russian)

16. Savarese G., Becher P.M., Lund L.H., Seferovic P., Rosano G.M.C., Coats A.J.S.. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118(17):3272-3287. doi: 10.1093/cvr/cvac013.

17. Lam C.S.P., Voors A.A., de Boer R.A., Solomon S.D., van Veldhuisen D.J. Heart failure with preserved ejection fraction: from mechanisms to therapies. Eur Heart J. 2018;39(30):2780-2792. doi: 10.1093/eurheartj/ehy301.

18. Tarlovskaya E.I. Comorbidity and polymorbidity -a modern interpretation and urgent tasks facing the therapeutic community. Kardiologiia. 2018;58(9S):29-38. doi:10.18087/cardio.2562. (In Russian)

19. Feinstein A.R. The pretherapeutic classification of comorbidity in chronic disease. J Chronic Dis. 1970;23 (7):455–68.

20. Gerhardt T., Gerhardt L.M.S., Ouwerkerk W., Roth G.A., Dickstein K., Collins S.P., Cleland J.G.F., Dahlstrom U., et al. Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study. Lancet Glob Health. 2023;11(12):e1874-e1884. doi: 10.1016/S2214-109X(23)00408-4.

21. Wang Y., Wang Y., Zhang W. The utility of the adjusted-OPTIMIZE-HF risk model for predicting in-hospital length of stay in the Chinese population. Ann Palliat Med. 2021;10(2):1445-1455. doi: 10.21037/apm-20-1209.

22. Kuan V., Denaxas S., Patalay P., Nitsch D., Mathur R., Gonzalez-Izquierdo A., Sofat R., Partridge L., et al. Multimorbidity Mechanism and Therapeutic Research Collaborative (MMTRC). Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study. Lancet Digit Health. 2023;5(1):e16-e27. doi: 10.1016/S2589-7500(22)00187-X.

23. Saczynski J.S., Go A.S., Magid D.J., Smith D.H., McManus D.D., Allen L., Ogarek J., Goldberg R.J., et al. Patterns of comorbidity in older adults with heart failure: the Cardiovascular Research Network PRESERVE study. J Am Geriatr Soc. 2013;61(1):26-33. doi: 10.1111/jgs.12062.

24. Nieminen M.S., Brutsaert D., Dickstein K., Drexler H., Follath F., Harjola V.P., Hochadel M., Komajda M., et al. EuroHeart Survey Investigators; Heart Failure Association, European Society of Cardiology. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006;27(22):2725-36. doi: 10.1093/eurheartj/ehl193.

25. Fonarow G.C. Strategies to improve the use of evidence-based heart failure therapies: OPTIMIZE-HF. Rev Cardiovasc Med. 2004;5 Suppl 1:S45-54.

26. Mebazaa A., Parissis J., Porcher R., Gayat E., Nikolaou M., Boas F.V., Delgado J.F., Follath F. Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods. Intensive Care Med. 2011;37(2):290-301. doi: 10.1007/s00134-010-2073-4.

27. Adams K.F. Jr., Fonarow G.C., Emerman C.L., LeJemtel T.H., Costanzo M.R., Abraham W.T., Berkowitz R.L., Galvao M., et al. ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149(2):209-16. doi: 10.1016/j.ahj.2004.08.005.

28. Tromp J., Tay W.T., Ouwerkerk W., Teng T.K., Yap J., MacDonald M.R., Leineweber K., McMurray J.J.V., et al. ASIAN-HF authors. Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry. PLoS Med. 2018;15(3):e1002541. doi: 10.1371/journal.pmed.1002541.

29. Lee K.S., Park DI., Lee J., Oh O, Kim N, Nam G. Relationship between comorbidity and health outcomes in patients with heart failure: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2023;23(1):498. doi: 10.1186/s12872-023-03527-x.

30. Corrales-Medina V.F., Serpa J., Rueda A.M., Giordano T.P.,Bozkurt B., Madjid M., Tweardy D., Musher D.M. Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes. Medicine (Baltimore). 2009;88(3):154-159. doi: 10.1097/MD.0b013e3181a692f0.

31. Dren E.A., Lyapina I.N., Golubovskaya D.P., Pecherina T.B.,Barbarash O.L. The relationship between body composition components in comorbid patients and the severity of acquired heart defects. Siberian Medical Review, (1 (151)), 91-97. (In Russ.)

32. Kapłon-Cieślicka A., Laroche C., Crespo-Leiro M.G., Coats A.J.S., Anker S.D., Filippatos G., Maggioni A.P., Hage C., et al. Heart Failure Association (HFA) of the European Society of Cardiology (ESC) and the ESC Heart Failure Long-Term Registry Investigators. Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term Registry. ESC Heart Fail. 2020;7(5):2098-2112. doi: 10.1002/ehf2.12817.

33. Barbarash O.L., Rejtblat O.M., Korennova O.Yu., Efremushkina A.A., Ustyugov S.A., Hramcova N.A., Makarov S.A., Alekseenko A.V., et al. Resolution following the expert council meeting "Improving the system of medical care for patients with cardiovascular diseases in the Siberian and Far Eastern Federal Districts within the framework of the federal project "Combating Cardiovascular Diseases." Focus on CHF.. Complex Issues of Cardiovascular Diseases. 2023;12(4S):206-209. doi:10.17802/2306-1278-2023-12-4S-206-209. (In Russan)